Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Perpetua Resources | PPTA | Nov 1, 2024 | 9.89 | -3.23 |
Perrigo | PRGO | Nov 1, 2024 | 26.09 | +1.79 |
Personalis | PSNL | Nov 1, 2024 | 5.09 | +0.79 |
Perspective Therapeutics | CATX | Nov 1, 2024 | 12.09 | +2.37 |
Petco Health And Wellness | WOOF | Nov 1, 2024 | 4.49 | +5.15 |
PetIQ A | PETQ | Nov 1, 2024 | 30.98 | 0.00 |
PetMed Express | PETS | Nov 1, 2024 | 4.19 | +2.20 |
Petroleo Brasileiro S.A.- Petrobras ADR | PBR | Nov 1, 2024 | 13.11 | -2.53 |
Petroleo Brasileiro S.A.- Petrobras ADR Pref | PBR-A | Nov 1, 2024 | 12.02 | -2.83 |
Petros Pharmaceuticals | PTPI | Nov 1, 2024 | 0.34 | -8.19 |
Pfizer | PFE | Nov 1, 2024 | 28.09 | -0.74 |
Pgim Global High Yield Fund | GHY | Nov 1, 2024 | 12.57 | -0.32 |
Pgim High Yield Bond Fund | ISD | Nov 1, 2024 | 14.08 | +0.28 |
PGIM Short Duration High Yield Opportunities Fund | SDHY | Nov 1, 2024 | 16.66 | +0.12 |
Pharmaceutical ETF Market Vectors | PPH | Nov 1, 2024 | 91.39 | +0.09 |
PharmaCyte Biotech | PMCB | Nov 1, 2024 | 1.83 | +1.11 |
Pharming Group ADR | PHAR | Nov 1, 2024 | 8.52 | -4.38 |
Pharvaris | PHVS | Nov 1, 2024 | 24.15 | -2.90 |
Phathom Pharmaceuticals | PHAT | Nov 1, 2024 | 18.27 | +6.53 |
PhenixFIN | PFX | Nov 1, 2024 | 47.23 | +0.49 |
Pheton | PTHL | Nov 1, 2024 | 3.86 | 0.00 |
Phibro Animal Health A | PAHC | Nov 1, 2024 | 23.18 | +0.26 |
Philip Morris | PM | Nov 1, 2024 | 130.65 | -1.54 |
Philippines Invstb Mkt Idx MSCI Ishares | EPHE | Nov 1, 2024 | 27.43 | +0.22 |
Phillips 66 | PSX | Nov 1, 2024 | 120.01 | -1.49 |
Phillips Edison & Company | PECO | Nov 1, 2024 | 37.80 | -0.03 |
PHINIA | PHIN | Nov 1, 2024 | 45.90 | -1.46 |
Phio Pharmaceuticals | PHIO | Nov 1, 2024 | 3.12 | +4.70 |
PHLX Semiconductor | SOX | Nov 1, 2024 | 5 001.42 | +1.11 |
PHLX Sox Semiconductor Sector Ishares | SOXX | Nov 1, 2024 | 220.58 | +1.06 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.